Heart transplantation indicated only in the most severely ill patient: Perspectives from the German heart transplant experience

Current Opinion in Cardiology

Volumn 16, Issue 2, 2001, Pages 97-104

  Deng, Mario C ^a   Smits, Jacqueline M A ^b   De Meester, Johan ^b   Hummel, Manfred ^c   Schoendube, Friedrich ^c   Scheld, Hans H ^d  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

^c German Transplantation Society   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INOTROPIC AGENT; MILRINONE; PIPERANOMETOZINE; PROSTACYCLIN; VASODILATOR AGENT;

ARTICLE; ASSISTED CIRCULATION; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DISEASE SEVERITY; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SURVIVAL;

ADULT; AGED; GERMANY; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RESEARCH; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0035094096     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200103000-00004     Document Type: Article

References (58)

1. 24th Bethesda Conference: Cardiac transplantation
2. The randomized controlled trial gets a middle-aged checkup
3. Effects of enalapril on mortality in severe congestive heart failure
4. The COPERNICUS trial results
5. Implantable left ventricular assist devices
6. Pretransplantation risk factors for death after transplantation: The Henry Mondor experience
7. The Registry of the international society for heart and lung transplantation: Seventeenth official report-2000
8. The relationship between experience and outcome in heart transplantation
9. Risk of mortality for UNOS status 3 liver recipients: A comparison of the risk posttransplant to the risk on the waiting list
10. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
11. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant
12. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
13. The effect of receiving a heart transplant: Analysis of a national cohort entered onto a waiting list, stratified by heart failure severity
14. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I
15. Coronary artery bypass surgery in patients with left ventricular dysfunction: Candidate selection and perioperative care
16. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy
17. Decision-making in end-stage coronary artery disease: Revascularization or heart transplantation?
18. Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival and improved EF and functional state
19. Coronary artery bypass surgery in patients with severe left ventricular dysfunction
20. Results of revascularization in patients with severe left ventricular dysfunction
21. Coronary surgery can be an alternative to heart transplantation in selected patients with end-stage ischemic heart disease
22. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy
23. Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: Longterm follow-up
24. The bad ventricle-revascularization versus transplantation
25. Intermediate-term outcome of mitral reconstruction in cardiomyopathy
26. Left ventricular reduction surgery with mitral valve repair
27. Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. InSync Study
28. The REMATCH trial: Rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure
29. Mechanical circulatory support for advanced heart failure: Effect of patient selection on outcome
30. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy
31. Recurrent remodeling after ventricular assistance: Is long-term myocardial recovery attainable?
32. Implantable axial flow impeller pumps
33. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation
34. Evaluation of surgical procedures. Changing patterns of patient selection and costs in heart transplantation
35. Ten-year follow-up of critically ill patients undergoing heart transplantation
36. Response of right ventricular function to prostaglandin E1 infusion predicts outcome for severe chronic heart failure patients awaiting urgent transplantation
37. Heart transplantation in patients 65 years of age and older: A comparative analysis of 40 patients
38. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: An analysis from the united network of organ sharing scientific registry
39. Cardiac transplantation in survivors of lymphoma: A multi-institutional survey
40. Medium-term results of heart transplantation using donors over 63 years of age
41. Changing patterns in donor and recipient risk: A 10-year evolution in one heart transplant center
42. Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database Group
43. Cardiac transplantation in over 1000 patients: A single institution experience from Columbia University
44. Likely variations in perioperative mortality associated with cardiac surgery: When does high mortality reflect bad practice?
45. The effect of transplant center volume on cardiac transplant outcome. A report of the United Network for Organ Sharing Scientific Registry
46. Heart transplant center practice patterns affect access to donors and survival of patients classified as status 1 by the United Network of Organ Sharing
47. Advancing knowledge in cardiac transplantation and the place of outcome analysis
48. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens
49. Selection and management of patients for cardiac transplantation
50. Development of cardiac transplant policy in Germany
51. Waiting for organ transplantation
52. Evidence-based medicine as Bayesian decision-making
53. Lung transplant waiting list: Differential outcome of type of end-stage lung disease, one year after registration
54. Time for a controlled trial?
55. A fair way of donating heads for transplantation
56. Cardiovascular news: Heart transplantation survival rate best in high-risk group
57. Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal